Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
0.0348
-0.0010 (-2.79%)
At close: Sep 18, 2026
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $88.5 thousand as of September 29, 2026. Its market cap has decreased by -98.43% in one year.
Market Cap
88.50K
Enterprise Value
2.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
ChartMarket Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 88.50K, a decrease of -99.87%. That is a compound annual growth rate of -67.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 88.50K | -96.78% |
| Dec 16, 2025 | 2.75M | -45.72% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regen BioPharma | 167.53K |
| Affymax | 119.18K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| GB Sciences | 105.88K |
| Itoco | 85.64K |
| ProtoKinetix | 82.33K |
| Vincerx Pharma | 78.51K |